期刊
PHARMACOGENETICS AND GENOMICS
卷 20, 期 1, 页码 9-17出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/FPC.0b013e328333bb28
关键词
bone mineral density; hypophosphatemia; phosphate transporter; PXR; PXR-null mouse; SLC34A2
资金
- NIH [Z01ES71005-01]
- NIEHS
- NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040] Funding Source: NIH RePORTER
Objective We previously found that the lack of nuclear xenobiotic receptor, PXR, decreases femoral bone mineral density (BMD) in Pxr(-/-) mice. Our present study aims to elucidate the inherited phenotype that correlates with the decreased BMD and to identify the PXR-regulated gene that may link with this phenotype. Methods Pxr(+/+) and Pxr(-/-) mice were used to measure the serum levels of inorganic phosphate (Pi), calcium and vitamin D-3. Real time PCR and western blots were used to determine the intestinal and renal expressions of Pi and calcium transporters and various other genes involved in bone homeostasis. Cell-based reporter and gel shift assays were performed to characterize the promoter of the identified PXR-regulated gene. Results In both Pxr(-/-) male and female mice, lumbar, sternum, and skull were all also found to have decreased their BMD values. Serum Pi levels, but not calcium levels, are attenuated in Pxr(-/-) mice, exhibiting a phenotype of hypophosphatemia. Among the members of the Na/Pi contransporter family, only the SLC34A2 mRNA and protein are repressed in Pxr(-/-) mice. PXR can directly activate the transcription of the SLC34A2 gene through an ER6 motif on its promoter. Conclusion Pxr(-/-) mice show the inherited phenotype of hypophosphatemia. The lack of PXR results in a severe repression of the Na/Pi cotransporter NaPi-IIb/Npt2b (SLC34A2), thus leading Pxr(-/-) males and females to develop a type of hypophosphatemia. Pharmacogenetics and Genomics 20:9-17 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据